6251 - 6260 of 8654 Results
Title
Year
- Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism2022OPENTitle: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 39End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.06.019Citation Count: 1
- The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin2019OPENTitle: The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and ParkinJournal Name: BiomoleculesPublisher: MDPI AGVol: 9Issue #: 8Start Page: 296End Page: 296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom9080296Best OA location URL: https://www.mdpi.com/2218-273X/9/8/296/pdfCitation Count: 22
- Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding2019OPENTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 35Issue #:Start Page: 42End Page: 47.e1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8074509Citation Count: 11
- Integrating multimodal and multiscale connectivity blueprints of the human cerebral cortex in health and disease2023OPENTitle: Integrating multimodal and multiscale connectivity blueprints of the human cerebral cortex in health and diseaseJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 21Issue #: 9Start Page: e3002314End Page: e3002314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3002314Best OA location URL: https://doi.org/10.1371/journal.pbio.3002314Citation Count: 38
- Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivo2017RESTRICTEDTitle: Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivoJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 123Issue #:Start Page: 34End Page: 45Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.05.011Citation Count: 11
-
RESTRICTEDTitle: RAB32 Variants in a German Parkinson's Disease CohortJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.30005Citation Count: 3
- Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease2018OPENTitle: Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0282-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0282-4Citation Count: 203
-
OPENTitle: Distinct AQP4 Alterations in Movement Disorders with Primary SynucleinopathyJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70023Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70023Citation Count: 0
- Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study2023OPENTitle: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 5Start Page: 407End Page: 417Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00109-6Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133500Citation Count: 465
-
OPENTitle: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitorsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.17111Best OA location URL: https://doi.org/10.7554/elife.17111Citation Count: 55